Related Experiment Video
Updated: Apr 8, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Association of interleukin-12 gene polymorphisms with cancer susceptibility: a meta-analysis
Su-Wen Chang1, Gui-Qin Xu2, Yong-Ling Fan1
1Department of Obstetrics and Gynecology, Yuhuangding Hospital Affiliated to Qingdao University Yantai 264000, P. R. China.
Objective:
To evaluate the association between interleukin-12 (IL-12) gene polymorphism and cervical cancer susceptibility.
Methods:
We comprehensively retrieved the relevant English and Chinese database to collect case-control studies on the association between the IL-12 gene polymorphism and cervical cancer susceptibility. Data were extracted independently by two researchers respectively, the summary data were analyzed using Revman 5.2 software, the association was described using odds ratios (OR) and 95% confidence intervals (95% CI).
Results:
According to inclusion and exclusion criteria, 5 case-control studies involving 2552 cervical cancer patients and 2232 healthy controls were included. The meta-analysis results showed that 3'UTR+1188 (rs3212227) polymorphism in IL-12 gene was not associated with cervical cancer risk (C vs. A: OR=1.09, 95% CI: 0.88~1.35, P=0.45; AA+AC vs. CC: OR=0.88, 95% CI: 0.67~1.15, P=0.34; AA vs. AC+CC: OR=0.89. 95% CI: 0.56-1.42, P=0.62; CC vs. AA: OR=1.30. 95% CI: 0.79-2.12, P=0.30).
Conclusion:
The available evidence suggested that rs3212227 polymorphism in IL-12 gene may not be the risk factor to cervical cancer.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Non-LTR Retrotransposons
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
